<DOC>
	<DOC>NCT00444340</DOC>
	<brief_summary>This study is an extension trial of 0881A3-312-EU and is designed to provide information on the safety and efficacy of etanercept in patients with ankylosing spondylitis for up to 3 additional years.</brief_summary>
	<brief_title>An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Completed study 0881A3312EU Agreeable to utilize medically acceptable form of contraception Able to reconstitute and selfinject or have a designee Withdrawn from study 0881A3312EU Abnormal hematology or chemistry profiles Clinically relevant medical conditions including: congestive heart failure, multiple sclerosis or other central demyelinating diseases, blood dyscrasias, cancer or serious infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>